A PROSPECTIVE, OPEN-LABEL, ONE ARM STUDY TO EVALUATE THE SAFETY AND EFFICACY OF THE REMEDIST ADVANCE HAIR GROWTH TONIC IN IMPROVEMENT OF HAIR GROWTH IN HEALTHY MALE OR FEMALE VOLUNTEERS

Believe Pte. Ltd0 个研究点目标入组 20 人开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•1.Willing to give informed consent.
•2.Healthy male/female volunteers with mild to moderate hair fall aged between 18-55 years.
•3.Must be able to adhere to the study visit schedule and other protocol requirements.
•4.Willing to complete the questionnaires for the total duration of 45 days.
•5.Willing to avoid usage of his/her own hair grooming products.

•1.Inability to provide voluntary consent.
•2.Patients with pre existing severe systemic disease necessitating long term medication.
•3.Subjects suffering from Trichotillomania a compulsive behaviour that necessitates pulling of hair.
•4.Evidence of significant uncontrolled co-morbid disease which in the investigators opinion would jeopardize patient participation.
•5.History of cancer, including solid tumors, hematologic malignancies and carcinoma in situ necessitating chemotherapy.
•6.Use of hair creams, hair shampoo and for one week prior to Baseline.
•7.Multivitamins, iron supplements and folate are acceptable, but should be used consistently throughout the study.
•8.Subjects who have had a hair head procedure (transplant) within 4 weeks before enrolment or during the study.
•9.Subjects who abuse drugs or alcohol (drug screening not required).
•10.Local (scalp) and systemic fungal infection
•11.History of recurrent bacterial infection (at least 3 major infections resulting in hospitalization and/or requiring intravenous antibiotic treatment within the past 2 years)
•12.Use of any investigational medication within 4 weeks prior to start of study.

发起方

Believe Pte. Ltd